Use of a proton-pump inhibitor for metabolic disturbances associated with anorexia nervosa.
Eiro
Masaaki
M
Katoh
Tetsuo
T
Watanabe
Tsuyoshi
T
D053799:2-Pyridinylmethylsulfinylbenzimidazoles; D000328:Adult; D000471:Alkalosis / Q000188:drug therapy* / Q000209:etiology; D000856:Anorexia Nervosa / Q000097:blood / Q000150:complications / Q000188:drug therapy*; D001639:Bicarbonates / Q000378:metabolism; D002032:Bulimia / Q000150:complications; D002712:Chlorides / Q000097:blood; D005260:Female; D006801:Humans; D007008:Hypokalemia / Q000188:drug therapy* / Q000209:etiology; D064747:Lansoprazole; D009853:Omeprazole / Q000031:analogs & derivatives* / Q000627:therapeutic use*; D054328:Proton Pump Inhibitors
D053799:2-Pyridinylmethylsulfinylbenzimidazoles; D001639:Bicarbonates; D002712:Chlorides; D054328:Proton Pump Inhibitors; D064747:Lansoprazole; D009853:Omeprazole